KRISTA DAL POZZO: Open Payments
NPI 1285408351 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,966 in 92 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $1,822 · 2025 $1,966
Food & beverage: $1,966
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $580 |
| Lilly USA, LLC | 16 | $359 |
| Novo Nordisk Inc | 17 | $346 |
| Axsome Therapeutics, Inc. | 11 | $228 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $128 |
| Esperion Therapeutics, Inc. | 5 | $81 |
| Aimmune Therapeutics, Inc. | 4 | $78 |
| Dexcom, Inc. | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Madrigal Pharmaceuticals | 1 | $26 |
Products named: VRAYLAR, Sunosi, QULIPTA, JARDIANCE, Wegovy, MOUNJARO, Kerendia, Ozempic.
Industry payments across IL — which companies pay providers there.
